Curcumin IV therapy

What is intravenous curcumin?

Curcumin is a substance found in turmeric. An intravenous preparation has a different formulation and route of administration from turmeric in food or an oral supplement. The preparation matters: evidence for one injectable formulation cannot automatically be applied to another.

At St. George Hospital, curcumin IV belongs to the infusion and immune therapy service. A recommendation is made within your wider plan, including coordination with oncology care where relevant.

What clinical studies have examined

A randomized trial in advanced breast cancer studied a specific intravenous curcumin preparation together with paclitaxel. It reported a higher objective response rate, but no significant difference in several other clinical outcomes. That result concerns this combination and patient group.

A separate phase I study of liposomal curcumin focused on safety in advanced cancers. It did not detect antitumour activity by its response criteria and reported haemolysis and haemoglobin reductions in some participants. These studies make formulation and medical monitoring central to the discussion.

Before an infusion is recommended

Your physician reviews the intended goal, the exact product, blood results, medicines and any previous reactions. An infusion can cause reactions even when the original substance is familiar from food. Tell the team about symptoms during administration, including pain at the line, rash, dizziness or breathing difficulty.

The consultation should make clear how the infusion fits your existing treatment and how its effects and tolerability will be assessed. Do not change prescribed cancer treatment or other medicines to accommodate an infusion without the treating team's advice.

Frequently asked questions